Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain is a research paper published in Molecular Psychiatry (2020). On theSindex it has a DataRank of 2.9. It has been cited 124 times, with 95 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.724
From this paper's citation signal
Citation Network Contribution
2.1
From 83 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 95 citers.
The Francis Crick Institute
Grant: 10194
Wellcome Trust
Grant: 217199/Z/19/Z
Parkinson's UK
Grant: G-0907
Wellcome Trust
Grant: 217199
Synaptic, Cellular and Neural Circuit Dysfunction in Down Syndrome
Wellcome Trust
Grant: 098330
The London Down Syndrome Consortium (LonDownS): An integrated system to study the development and therapeutic amelioration of cognition and dementia.
Medical Research Council
Grant: UKDRI-1009
Wellcome Trust
Grant: 098327/Z/12/Z
European Research Council
Grant: 720931
Medical Research Council
Grant: G0701075
Medical Research Council
Grant: G0901254
Medical Research Council
Grant: MR/S011277/1
Rosetrees
Grant: M733
Medical Research Council
Grant: MR/N026004/1
Wellcome Trust
Grant: 098330/Z/12/Z
Medical Research Council
Grant: MR/L501542/1
Medical Research Council
Grant: MR/R024901/1
NIA NIH HHS
Grant: RF1 AG059695
National Institutes of Health
Grant: 1RF1AG059695-01A1
Relevance of Abeta N-terminal Truncations for Alzheimer Pathogenesis and Therapy - Resubmission - 1
European Commission
Grant: 608765
WILLIAM HARVEY INTERNATIONAL TRANSLATIONAL RESEARCH ACADEMY
Wellcome Trust
Grant: 98330
The London Down Syndrome Consortium (LonDownS): An integrated system to study the development and therapeutic amelioration of cognition and dementia.
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
Additional file 1 of Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B